Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOS-comedy: PCI vs OMT for Single CTO Lesions
NCT02767401Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Sep 2015
- Primary completion
- Aug 2018
01
Overview
Phase 4, open-label trial (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Changes to myocardial viability at 12 months. Started Sep 2015; status: completed.
Beyond the preview
Go deeper on NCT02767401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767401.